Last reviewed · How we verify
SPC 2003
At a glance
| Generic name | SPC 2003 |
|---|---|
| Sponsor | Shin Poong Pharmaceutical Co. Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- LH/FSH, Testosterone, Prolactin, and Ferritin in PCOS Patients in Jordan
- Efficacy and Safety of SPC1001 in Patients With Essential Hypertension (PHASE2)
- Education Effectiveness for Type 1 Diabetes Mellitus on Insulin Pump Therapy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SPC 2003 CI brief — competitive landscape report
- SPC 2003 updates RSS · CI watch RSS
- Shin Poong Pharmaceutical Co. Ltd. portfolio CI